Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of of HZBio1 in Healthy Subjects

NCT04765995 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: HZBio1 0.96mg / kg
DRUG: HZBio1 3mg / kg
DRUG: HZBio1 6mg / kg
DRUG: HZBio1 9mg / kg
DRUG: HZBio1 12mg / kg
DRUG: Placebo

Sponsor

Hangzhou Grand Biologic Pharmaceutical, Inc.

Collaborators

[object Object]